The prognosticator behind that piece of bad news was Citigroup's Joanne Wuensch, who issued one of her bank's 90-day catalyst watches on Tandem stock before the market open. Wuensch wrote in her ...
Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 5.5% in the afternoon session after the U.S. government opened an investigation into the national security implications of ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results tomorrow after the bell. Here’s what you need to know. Tandem Diabetes beat analysts’ revenue expectations by 0 ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 ...
More than 200 people with diabetes were injured when their insulin pumps shut down unexpectedly due to a problem with a connected mobile app, the US Food and Drug Administration said Wednesday.
A top bank opened one of its negative catalyst watches on the medical devices specialist. Despite that, it remains bullish on Tandem's prospects. The prognosticator behind that piece of bad news was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results